APO Research
Talk to an analyst

APO RESEARCH · REPORT

Antibiotics

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Antibiotics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

20 December 2025191 pages

Choose your research edition.

Industry ResearchAntibiotics Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Antibiotics Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Antibiotics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Antibiotics Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Antibiotics Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Antibiotics market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Antibiotics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Antibiotics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Antibiotics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Antibiotics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Antibiotics include Astellas Pharma, Bristol Myers Squibb Company, Janssen Pharmaceuticals, Bayer, GlaxoSmithKline, Pfizer, Eli Lilly and Company, Novartis and Sanofi, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Antibiotics market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Antibiotics and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Antibiotics sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Antibiotics market size, projected growth trends, production technologies, key applications, and end-use industries.

Antibiotics Segment by Company

Astellas Pharma

Bristol Myers Squibb Company

Janssen Pharmaceuticals

Bayer

GlaxoSmithKline

Pfizer

Eli Lilly and Company

Novartis

Sanofi

Abbott

Antibiotics Segment by Type

Cephalosporins

Macrolides

Sulfonamides

Others

Penicillins

Aminoglycosides

Tetracyclines

Antibiotics Segment by Application

Poultry

Livestock

Other

Antibiotics Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antibiotics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Antibiotics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antibiotics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Antibiotics market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Antibiotics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Antibiotics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Antibiotics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Antibiotics Industry Trends Table 2. Antibiotics Industry Drivers Table 3. Antibiotics Industry Opportunities and Challenges Table 4. Antibiotics Industry Restraints Table 5. Global Antibiotics Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Antibiotics Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Antibiotics Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Antibiotics Sales Market Share by Manufacturers Table 9. Global Antibiotics Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Antibiotics Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Antibiotics Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Antibiotics Manufacturers, Product Type & Application Table 13. Global Antibiotics Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Antibiotics by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Cephalosporins Table 17. Major Manufacturers of Macrolides Table 18. Major Manufacturers of Sulfonamides Table 19. Major Manufacturers of Others Table 20. Major Manufacturers of Penicillins Table 21. Major Manufacturers of Aminoglycosides Table 22. Major Manufacturers of Tetracyclines Table 23. Global Antibiotics Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Antibiotics Sales by Type (2021-2026) & (K Units) Table 25. Global Antibiotics Sales by Type (2027-2032) & (K Units) Table 26. Global Antibiotics Sales Market Share by Type (2021-2026) Table 27. Global Antibiotics Sales Market Share by Type (2027-2032) Table 28. Global Antibiotics Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 29. Global Antibiotics Revenue by Type (2021-2026) & (K Units) Table 30. Global Antibiotics Revenue by Type (2027-2032) & (K Units) Table 31. Global Antibiotics Revenue Market Share by Type (2021-2026) Table 32. Global Antibiotics Revenue Market Share by Type (2027-2032) Table 33. Major Manufacturers of Poultry Table 34. Major Manufacturers of Livestock Table 35. Major Manufacturers of Other Table 36. Global Antibiotics Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Antibiotics Sales by Application (2021-2026) & (K Units) Table 38. Global Antibiotics Sales by Application (2027-2032) & (K Units) Table 39. Global Antibiotics Sales Market Share by Application (2021-2026) Table 40. Global Antibiotics Sales Market Share by Application (2027-2032) Table 41. Global Antibiotics Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 42. Global Antibiotics Revenue by Application (2021-2026) & (K Units) Table 43. Global Antibiotics Revenue by Application (2027-2032) & (K Units) Table 44. Global Antibiotics Revenue Market Share by Application (2021-2026) Table 45. Global Antibiotics Revenue Market Share by Application (2027-2032) Table 46. Global Antibiotics Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 47. Global Antibiotics Sales by Region (2021-2026) & (K Units) Table 48. Global Antibiotics Sales Market Share by Region (2021-2026) Table 49. Global Antibiotics Sales Forecasted by Region (2027-2032) & (K Units) Table 50. Global Antibiotics Sales Forecasted Market Share by Region (2027-2032) Table 51. North America Antibiotics Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. North America Antibiotics Sales by Country (2021-2026) & (K Units) Table 53. North America Antibiotics Sales by Country (2027-2032) & (K Units) Table 54. Europe Antibiotics Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Europe Antibiotics Sales by Country (2021-2026) & (K Units) Table 56. Europe Antibiotics Sales by Country (2027-2032) & (K Units) Table 57. Asia Pacific Antibiotics Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. Asia Pacific Antibiotics Sales by Country (2021-2026) & (K Units) Table 59. Asia Pacific Antibiotics Sales by Country (2027-2032) & (K Units) Table 60. South America, Middle East and Africa Antibiotics Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 61. South America, Middle East and Africa Antibiotics Sales by Country (2021-2026) & (K Units) Table 62. South America, Middle East and Africa Antibiotics Sales by Country (2027-2032) & (K Units) Table 63. Global Antibiotics Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 64. Global Antibiotics Revenue by Region (2021-2026) & (US$ Million) Table 65. Global Antibiotics Revenue by Region (2027-2032) & (US$ Million) Table 66. Global Antibiotics Revenue Market Share by Region (2021-2026) Table 67. Global Antibiotics Revenue Market Share by Region (2027-2032) Table 68. Astellas Pharma Company Information Table 69. Astellas Pharma Business Overview Table 70. Astellas Pharma Antibiotics Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Astellas Pharma Antibiotics Product Portfolio Table 72. Astellas Pharma Recent Development Table 73. Bristol Myers Squibb Company Company Information Table 74. Bristol Myers Squibb Company Business Overview Table 75. Bristol Myers Squibb Company Antibiotics Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Bristol Myers Squibb Company Antibiotics Product Portfolio Table 77. Bristol Myers Squibb Company Recent Development Table 78. Janssen Pharmaceuticals Company Information Table 79. Janssen Pharmaceuticals Business Overview Table 80. Janssen Pharmaceuticals Antibiotics Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Janssen Pharmaceuticals Antibiotics Product Portfolio Table 82. Janssen Pharmaceuticals Recent Development Table 83. Bayer Company Information Table 84. Bayer Business Overview Table 85. Bayer Antibiotics Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Bayer Antibiotics Product Portfolio Table 87. Bayer Recent Development Table 88. GlaxoSmithKline Company Information Table 89. GlaxoSmithKline Business Overview Table 90. GlaxoSmithKline Antibiotics Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. GlaxoSmithKline Antibiotics Product Portfolio Table 92. GlaxoSmithKline Recent Development Table 93. Pfizer Company Information Table 94. Pfizer Business Overview Table 95. Pfizer Antibiotics Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Pfizer Antibiotics Product Portfolio Table 97. Pfizer Recent Development Table 98. Eli Lilly and Company Company Information Table 99. Eli Lilly and Company Business Overview Table 100. Eli Lilly and Company Antibiotics Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Eli Lilly and Company Antibiotics Product Portfolio Table 102. Eli Lilly and Company Recent Development Table 103. Novartis Company Information Table 104. Novartis Business Overview Table 105. Novartis Antibiotics Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Novartis Antibiotics Product Portfolio Table 107. Novartis Recent Development Table 108. Sanofi Company Information Table 109. Sanofi Business Overview Table 110. Sanofi Antibiotics Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Sanofi Antibiotics Product Portfolio Table 112. Sanofi Recent Development Table 113. Abbott Company Information Table 114. Abbott Business Overview Table 115. Abbott Antibiotics Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Abbott Antibiotics Product Portfolio Table 117. Abbott Recent Development Table 118. Key Raw Materials Table 119. Raw Materials Key Suppliers Table 120. Antibiotics Distributors List Table 121. Antibiotics Customers List Table 122. Research Programs/Design for This Report Table 123. Authors List of This Report Table 124. Secondary Sources Table 125. Primary Sources List of Figures Figure 1. Antibiotics Product Image Figure 2. Global Antibiotics Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Antibiotics Market Size (2021-2032) & (US$ Million) Figure 4. Global Antibiotics Sales (2021-2032) & (K Units) Figure 5. Global Antibiotics Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Antibiotics Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Cephalosporins Image Figure 9. Macrolides Image Figure 10. Sulfonamides Image Figure 11. Others Image Figure 12. Penicillins Image Figure 13. Aminoglycosides Image Figure 14. Tetracyclines Image Figure 15. Global Antibiotics Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 16. Global Antibiotics Sales Market Share 2021 VS 2025 VS 2032 Figure 17. Global Antibiotics Sales Market Share by Type (2021-2032) Figure 18. Global Antibiotics Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 19. Global Antibiotics Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global Antibiotics Revenue Market Share by Type (2021-2032) Figure 21. Poultry Image Figure 22. Livestock Image Figure 23. Other Image Figure 24. Global Antibiotics Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 25. Global Antibiotics Sales Market Share 2021 VS 2025 VS 2032 Figure 26. Global Antibiotics Sales Market Share by Application (2021-2032) Figure 27. Global Antibiotics Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 28. Global Antibiotics Revenue Market Share 2021 VS 2025 VS 2032 Figure 29. Global Antibiotics Revenue Market Share by Application (2021-2032) Figure 30. North America Antibiotics Sales and Growth Rate (2021-2032) & (K Units) Figure 31. North America Antibiotics Sales Market Share by Country (2021-2032) Figure 32. U.S. Antibiotics Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Canada Antibiotics Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Mexico Antibiotics Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Europe Antibiotics Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Europe Antibiotics Sales Market Share by Country (2021-2032) Figure 37. Germany Antibiotics Sales and Growth Rate (2021-2032) & (K Units) Figure 38. France Antibiotics Sales and Growth Rate (2021-2032) & (K Units) Figure 39. U.K. Antibiotics Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Italy Antibiotics Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Netherlands Antibiotics Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Asia Pacific Antibiotics Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Asia Pacific Antibiotics Sales Market Share by Country (2021-2032) Figure 44. China Antibiotics Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Japan Antibiotics Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South Korea Antibiotics Sales and Growth Rate (2021-2032) & (K Units) Figure 47. Southeast Asia Antibiotics Sales and Growth Rate (2021-2032) & (K Units) Figure 48. India Antibiotics Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Australia Antibiotics Sales and Growth Rate (2021-2032) & (K Units) Figure 50. South America, Middle East and Africa Antibiotics Sales and Growth Rate (2021-2032) & (K Units) Figure 51. South America, Middle East and Africa Antibiotics Sales Market Share by Country (2021-2032) Figure 52. Brazil Antibiotics Sales and Growth Rate (2021-2032) & (K Units) Figure 53. South Africa Antibiotics Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Saudi Arabia Antibiotics Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Turkey Antibiotics Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Argentina Antibiotics Sales and Growth Rate (2021-2032) & (K Units) Figure 57. UAE Antibiotics Sales and Growth Rate (2021-2032) & (K Units) Figure 58. Egypt Antibiotics Sales and Growth Rate (2021-2032) & (K Units) Figure 59. Chile Antibiotics Sales and Growth Rate (2021-2032) & (K Units) Figure 60. Global Antibiotics Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 61. Global Antibiotics Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 62. North America Antibiotics Revenue (2021-2032) & (US$ Million) Figure 63. North America Antibiotics Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Europe Antibiotics Revenue (2021-2032) & (US$ Million) Figure 65. Europe Antibiotics Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Asia-Pacific Antibiotics Revenue (2021-2032) & (US$ Million) Figure 67. Asia-Pacific Antibiotics Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. South America, Middle East and Africa Antibiotics Revenue (2021-2032) & (US$ Million) Figure 69. South America, Middle East and Africa Antibiotics Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 70. Antibiotics Value Chain Figure 71. Manufacturing Cost Structure Figure 72. Antibiotics Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Cephalosporins
  • Macrolides
  • Sulfonamides
  • Others
  • Penicillins
  • Aminoglycosides
  • Tetracyclines
Applications
  • Poultry
  • Livestock
  • Other
Companies covered
  • Astellas Pharma
  • Bristol Myers Squibb Company
  • Janssen Pharmaceuticals
  • Bayer
  • GlaxoSmithKline
  • Pfizer
  • Eli Lilly and Company
  • Novartis
  • Sanofi
  • Abbott

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Antibiotics Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Antibiotics Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Antibiotics Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Antibiotics Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Antibiotics Market Dynamics
  1. 2.1 Antibiotics Industry Trends
  2. 2.2 Antibiotics Industry Drivers
  3. 2.3 Antibiotics Industry Opportunities and Challenges
  4. 2.4 Antibiotics Industry Restraints
3 Antibiotics Market by Manufacturers
  1. 3.1 Global Antibiotics Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Antibiotics Sales by Manufacturers (2021-2026)
  3. 3.3 Global Antibiotics Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Antibiotics Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Antibiotics Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Antibiotics Manufacturers, Product Type & Application
  7. 3.7 Global Antibiotics Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Antibiotics Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Antibiotics Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Antibiotics Tier 1, Tier 2, and Tier 3
4 Antibiotics Market by Type
  1. 4.1 Antibiotics Type Introduction
  2. 4.1.1 Cephalosporins
  3. 4.1.2 Macrolides
  4. 4.1.3 Sulfonamides
  5. 4.1.4 Others
  6. 4.1.5 Penicillins
  7. 4.1.6 Aminoglycosides
  8. 4.1.7 Tetracyclines
  9. 4.2 Global Antibiotics Sales by Type
  10. 4.2.1 Global Antibiotics Sales by Type (2021 VS 2025 VS 2032)
  11. 4.2.2 Global Antibiotics Sales by Type (2021-2032)
  12. 4.2.3 Global Antibiotics Sales Market Share by Type (2021-2032)
  13. 4.3 Global Antibiotics Revenue by Type
  14. 4.3.1 Global Antibiotics Revenue by Type (2021 VS 2025 VS 2032)
  15. 4.3.2 Global Antibiotics Revenue by Type (2021-2032)
  16. 4.3.3 Global Antibiotics Revenue Market Share by Type (2021-2032)
5 Antibiotics Market by Application
  1. 5.1 Antibiotics Application Introduction
  2. 5.1.1 Poultry
  3. 5.1.2 Livestock
  4. 5.1.3 Other
  5. 5.2 Global Antibiotics Sales by Application
  6. 5.2.1 Global Antibiotics Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Antibiotics Sales by Application (2021-2032)
  8. 5.2.3 Global Antibiotics Sales Market Share by Application (2021-2032)
  9. 5.3 Global Antibiotics Revenue by Application
  10. 5.3.1 Global Antibiotics Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Antibiotics Revenue by Application (2021-2032)
  12. 5.3.3 Global Antibiotics Revenue Market Share by Application (2021-2032)
6 Global Antibiotics Sales by Region
  1. 6.1 Global Antibiotics Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Antibiotics Sales by Region (2021-2032)
  3. 6.2.1 Global Antibiotics Sales by Region (2021-2026)
  4. 6.2.2 Global Antibiotics Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Antibiotics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Antibiotics Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Antibiotics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Antibiotics Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Antibiotics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Antibiotics Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Antibiotics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Antibiotics Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Antibiotics Revenue by Region
  1. 7.1 Global Antibiotics Revenue by Region
  2. 7.1.1 Global Antibiotics Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Antibiotics Revenue by Region (2021-2026)
  4. 7.1.3 Global Antibiotics Revenue by Region (2027-2032)
  5. 7.1.4 Global Antibiotics Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Antibiotics Revenue (2021-2032)
  8. 7.2.2 North America Antibiotics Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Antibiotics Revenue (2021-2032)
  11. 7.3.2 Europe Antibiotics Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Antibiotics Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Antibiotics Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Antibiotics Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Antibiotics Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Astellas Pharma
  2. 8.1.1 Astellas Pharma Company Information
  3. 8.1.2 Astellas Pharma Business Overview
  4. 8.1.3 Astellas Pharma Antibiotics Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Astellas Pharma Antibiotics Product Portfolio
  6. 8.1.5 Astellas Pharma Recent Developments
  7. 8.2 Bristol Myers Squibb Company
  8. 8.2.1 Bristol Myers Squibb Company Company Information
  9. 8.2.2 Bristol Myers Squibb Company Business Overview
  10. 8.2.3 Bristol Myers Squibb Company Antibiotics Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Bristol Myers Squibb Company Antibiotics Product Portfolio
  12. 8.2.5 Bristol Myers Squibb Company Recent Developments
  13. 8.3 Janssen Pharmaceuticals
  14. 8.3.1 Janssen Pharmaceuticals Company Information
  15. 8.3.2 Janssen Pharmaceuticals Business Overview
  16. 8.3.3 Janssen Pharmaceuticals Antibiotics Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Janssen Pharmaceuticals Antibiotics Product Portfolio
  18. 8.3.5 Janssen Pharmaceuticals Recent Developments
  19. 8.4 Bayer
  20. 8.4.1 Bayer Company Information
  21. 8.4.2 Bayer Business Overview
  22. 8.4.3 Bayer Antibiotics Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Bayer Antibiotics Product Portfolio
  24. 8.4.5 Bayer Recent Developments
  25. 8.5 GlaxoSmithKline
  26. 8.5.1 GlaxoSmithKline Company Information
  27. 8.5.2 GlaxoSmithKline Business Overview
  28. 8.5.3 GlaxoSmithKline Antibiotics Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 GlaxoSmithKline Antibiotics Product Portfolio
  30. 8.5.5 GlaxoSmithKline Recent Developments
  31. 8.6 Pfizer
  32. 8.6.1 Pfizer Company Information
  33. 8.6.2 Pfizer Business Overview
  34. 8.6.3 Pfizer Antibiotics Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Pfizer Antibiotics Product Portfolio
  36. 8.6.5 Pfizer Recent Developments
  37. 8.7 Eli Lilly and Company
  38. 8.7.1 Eli Lilly and Company Company Information
  39. 8.7.2 Eli Lilly and Company Business Overview
  40. 8.7.3 Eli Lilly and Company Antibiotics Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Eli Lilly and Company Antibiotics Product Portfolio
  42. 8.7.5 Eli Lilly and Company Recent Developments
  43. 8.8 Novartis
  44. 8.8.1 Novartis Company Information
  45. 8.8.2 Novartis Business Overview
  46. 8.8.3 Novartis Antibiotics Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Novartis Antibiotics Product Portfolio
  48. 8.8.5 Novartis Recent Developments
  49. 8.9 Sanofi
  50. 8.9.1 Sanofi Company Information
  51. 8.9.2 Sanofi Business Overview
  52. 8.9.3 Sanofi Antibiotics Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Sanofi Antibiotics Product Portfolio
  54. 8.9.5 Sanofi Recent Developments
  55. 8.10 Abbott
  56. 8.10.1 Abbott Company Information
  57. 8.10.2 Abbott Business Overview
  58. 8.10.3 Abbott Antibiotics Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Abbott Antibiotics Product Portfolio
  60. 8.10.5 Abbott Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Antibiotics Value Chain Analysis
  2. 9.1.1 Antibiotics Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Antibiotics Production Mode & Process
  6. 9.2 Antibiotics Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Antibiotics Distributors
  9. 9.2.3 Antibiotics Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst